TNYAHealthcareMicro-Cap
Tenaya Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Tenaya Therapeutics, Inc. (TNYA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are TNYA insiders buying or selling?
Tenaya Therapeutics, Inc. insiders reported 18 open-market buys ($161.7M) and 37 sells ($6.4M) across 55 Form 4 filings — a net buying position of $155.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of May 19, 2026)
Total Form 4 filings
55
SEC EDGAR
Insider filers
11
Insider buys (18)
$161.7M
Insider sells (37)
$6.4M
Insider sentiment
Net buyingNet insider flow of $155.3M in net buying.
Recent TNYA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 19, 2026 | Faraz Ali | Chief Executive Officer | Sale | 3.4K | $0.79 | $2.7K |
| May 19, 2026 | Whittemore Tingley | Chief Medical Officer | Sale | 3.1K | $0.79 | $2.5K |
| May 19, 2026 | Tomohiro Higa | SVP, Finance | Sale | 1.5K | $0.79 | $1.2K |
| Feb 26, 2026 | Tim Kutzkey | 10% Owner | Sale | 4.2M | $0.57 | $2.4M |
| Feb 24, 2026 | Tim Kutzkey | 10% Owner | Sale | 829.7K | $0.61 | $504.8K |
| Feb 18, 2026 | Tomohiro Higa | SVP, Finance | Sale | 3.5K | $0.64 | $2.2K |
| Feb 18, 2026 | Faraz Ali | Chief Executive Officer | Sale | 14.9K | $0.64 | $9.6K |
| Feb 18, 2026 | Whittemore Tingley | Chief Medical Officer | Sale | 5.2K | $0.64 | $3.3K |
| Feb 12, 2026 | Tim Kutzkey | 10% Owner | Sale | 4.4M | $0.69 | $3.0M |
| Nov 18, 2025 | Tomohiro Higa | SVP, Finance | Sale | 1.4K | $1.33 | $1.8K |
| Nov 18, 2025 | Whittemore Tingley | Chief Medical Officer | Sale | 2.9K | $1.33 | $3.8K |
| Nov 18, 2025 | Faraz Ali | Chief Executive Officer | Sale | 3.1K | $1.33 | $4.2K |
| Aug 19, 2025 | Tomohiro Higa | SVP, Finance | Sale | 3.0K | $1.25 | $3.7K |
| Aug 19, 2025 | Whittemore Tingley | Chief Medical Officer | Sale | 5.1K | $1.25 | $6.3K |
| Aug 19, 2025 | Faraz Ali | Chief Executive Officer | Sale | 14.5K | $1.25 | $18.2K |
| May 16, 2025 | Tomohiro Higa | SVP, Finance | Sale | 1.4K | $0.44 | $615.35 |
| May 16, 2025 | Whittemore Tingley | Chief Medical Officer | Sale | 2.9K | $0.44 | $1.3K |
| May 16, 2025 | Faraz Ali | Chief Executive Officer | Sale | 3.2K | $0.44 | $1.4K |
| Mar 11, 2025 | Tomohiro Higa | SVP, Finance | Sale | 2.5K | $0.54 | $1.3K |
| Mar 11, 2025 | Whittemore Tingley | Chief Medical Officer | Sale | 7.4K | $0.54 | $4.0K |
| Mar 11, 2025 | Faraz Ali | Chief Executive Officer | Sale | 9.7K | $0.54 | $5.2K |
| Mar 8, 2025 | COLUMN GROUP III GP, LP | 10% Owner | Purchase | 35.7M | $0.70 | $25.0M |
| Mar 8, 2025 | David V Goeddel | Director, 10% Owner | Purchase | 35.7M | $0.70 | $25.0M |
| Nov 19, 2024 | Chihiro Saito | SVP, Accounting and Fin. Ops. | Sale | 2.3K | $2.12 | $4.8K |
| Aug 20, 2024 | Chihiro Saito | SVP, Accounting and Fin. Ops. | Sale | 2.4K | $2.89 | $6.8K |
Showing the 25 most recent of 55 Form 4 filings for Tenaya Therapeutics, Inc..
Most active TNYA insiders
- COLUMN GROUP III GP, LP10 filings
- Faraz Ali9 filings
- Whittemore Tingley9 filings
- David V Goeddel7 filings
- Timothy Hoey6 filings
Ask anything about TNYA insider activity
Use Trabud's AI agent to query Tenaya Therapeutics, Inc.'s Form 4 history in plain English — "Show me TNYA CEO purchases this year" or compare it against any other ticker.
Open the AI agentTNYA insider trading FAQ
Are Tenaya Therapeutics, Inc. insiders buying or selling?
Across 55 SEC Form 4 filings, Tenaya Therapeutics, Inc. (TNYA) insiders reported 18 open-market purchases totaling $161.7M and 37 sales totaling $6.4M. That is a net buying position of $155.3M.
How many insiders trade TNYA stock?
11 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Tenaya Therapeutics, Inc.. The most recent filing was accepted on May 19, 2026.
Where does Trabud get TNYA insider trading data?
All TNYA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.